[1] Ward P,Walsh CE. Current and future prospects for hemophilia gene therapy[J].Expert Rev Hematol,2016,4(6):335-341.
[2] Perez Ruiz,Garibay A.Endocytosis in gene therapy with non-viral vectors[J].Wien Med Wochenschr,2016,2(3):556-562.
[3] Pergament E.The promise of gene therapy[J].Curr Opin Obstet Gynecol,2016,28(2):132-135.
[4] Machelska H,Schroff M,Oswald D,et al.Peripheral non-viral MIDGE vector-driven delivery of β-endorphin in inflammatory pain[J].Mol Pain,2009,5(6):72-85.
[5] López-Fuertes L,Pérez-Jiménez E,Vila-Coro AJ,et al.DNA vaccination with linear minimalistic(MIDGE) vectors confers protection against Leishmania major infection in mice[J].Vaccine,2002,21(4):247-257.
[6] Zheng C,Juhls C,Oswald D,et al.Effect of different nuclear localization sequences on theimmune responses induced by a MIDGE vector encoding bovine herpesvirus-1 glycoprotein D[J].Vaccine,2006,24(21):4625-4629.
[7] Chen ZY,He CY,Ehrhardt A,et al.Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo[J].Mol Ther,2004,8(3):495-500.
[8] Wei L,Han T,Yang D,et al.Simeprevir plus peginterferon/ribavirin for HCV genotype 1-infected treatment-naïve patients in China and South Korea[J].J Gastroenterol Hepatol,2016,31(5):912-920.
[9] Christiane L,Schnabel P,Steinig M,et al.Immune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagent[J].BMC Vet Res,2015,11(10):140-144.
[10] Agarwal A,Ingham SA,Harkins KA.The role of pharmacogenetics and advances in gene therapy in the treatment of diabetic retinopathy[J].Pharmacogenomics,2016,17(3):309-320.
[11] Pahle J,Walther W.Vectors and strategies for nonviral cancer gene therapy[J].Expert Opin Biol Ther,2016,16(4):443-461.
[12] Campbell JP,McFarland TJ,Stout JT.Ocular gene therapy[J].Dev Ophthalmol,2016,55(3):317-321.
[13] 韩笑,麻树人,王大全,等.早期骨癌外周血细胞免疫功能状况变化研究[J].中国实用内科杂志,2015,35(9):759-761.
[14] 李修明.基于DC-CIK细胞免疫治疗联合化疗治疗晚期消化道肿瘤的临床疗效分析[J].中国实用内科杂志,2015,35(增1):119-121. |